Skip to content

Comparing the effectiveness of two steroid drugs (methylprednisolone and triamcinolone) in epidural injection to reduce chronic pain in lower back and legs

Comparison of the efficacy of fluoroscopic guided caudal epidural injection of methylprednisolone versus triamcinolone in patients with degenerative lumbar canal stenosis - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/068152
Enrollment
60
Registered
2024-05-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M480- Spinal stenosis

Interventions

Intervention1: caudal epidural injection of triamcinolone acetonide with hyaluronidase: Fluroscopic guided caudal epidural injection of triamcinolone acetonide with hyaluronidase as adjuvant will be

Sponsors

Government Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Clinically diagnosed signs and symptoms suggestive of neurogenic claudication pain refractory to conservative treatment for more than 3 months. 2. Age range between 40 and 80 years. 3. Magnetic Resonance Imaging (MRI) based Lee’s Grading 1 to 3 for lumbar central canal or foraminal stenosis.

Exclusion criteria

Exclusion criteria: 1. Previous history of lumbar surgery 2. Back or leg pain due to other etiologies (e.g. spinal fracture, metastasis, neuropathy, vascular claudication etc.) 3. Pregnancy and lactating women 4. Severe bleeding diathesis or on anticoagulation therapy 5. Patient with severe heart, lung, hepatic, renal, psychiatric, connective tissue disorder, neurological, uncontrolled diabetes mellites or hypertension 6. Presence of systemic infection or local infection at the injection site 7. Significant allergic reaction or hypersensitivity to contrast, anaesthetic, or corticosteroids 8. Patient diagnosed with malignancy 9. Patient on uncontrollable or unstable opioid use 10. Patient having severe motor weakness, rapidly progressing neurological deficit, or cauda equina syndrome

Design outcomes

Primary

MeasureTime frame
To compare the analgesic efficacy of fluoroscopically guided caudal epidural injection of methylprednisolone versus triamcinolone with hyaluronidase as adjuvant, using ‘visual analogue scale’ in patients with lumbar canal stenosis.Timepoint: Pain assessment of patient by VAS score at pre-intervention, 1, 2, and 3-month post- intervention.

Secondary

MeasureTime frame
1. To compare the functional outcomes achieved by administering fluoroscopically guided caudal epidural injection of methylprednisolone versus triamcinolone with hyaluronidase as adjuvant, using ‘Swiss Spinal Stenosis’ score.Timepoint: Functional status of patient by SSS score at pre-intervention, 1, 2, and 3-month post- intervention.;2. To compare the patient satisfaction outcomes achieved by administering fluoroscopically guided caudal epidural injection of methylprednisolone versus triamcinolone with hyaluronidase as adjuvant, using five-point ‘Likert scale’.Timepoint: Patient satisfaction level by Likert 5 -point scale at pre-intervention, 1, 2, and 3-month post-intervention.

Countries

India

Contacts

Public ContactDr M Priyadarshini

Government Medical College and Hospital,Chandigarh Sector 32

kapoor.dheeraj72@gmail.com9646121549

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026